Former Chief Financial Officer (8) · Aurinia Pharmaceuticals Inc. (AUPH)

Dennis Bourgeault

A named executive officer of Aurinia Pharmaceuticals in every fiscal year CompBrief holds from FY2018 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$703,715

Salary $88,426Stock awards $0

FY2019: $580,847

7th of 7 named executive officers at Aurinia Pharmaceuticals by FY2020 total.

7 named officers on file for Aurinia Pharmaceuticals, FY2020

Dennis Bourgeault’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing
  • AUPH’s disclosed peer group of 20 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Aurinia Pharmaceuticals’s whole pay program stands against its peers

  • Aurinia Pharmaceuticals’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on AUPH→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed May 10, 2021 (DEF 14A).

Free

Get Dennis Bourgeault’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Dennis Bourgeault compensation by year

Aurinia Pharmaceuticals Summary Compensation Table · all 3 fiscal years held
In US dollars, as Aurinia Pharmaceuticals reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2018FY2019FY2020
Salary$242,969$270,145$88,426
Bonus$0$0$0
Stock awards$0$0$0
Option awards$351,432$180,784$399,825
Non-equity incentive$86,220$126,205$121,992
Pension and deferred compensation$0$0$0
All other$0$3,713$93,472
Total$680,621$580,847$703,715

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Aurinia Pharmaceuticals Inc. DEF 14A filed May 10, 2021, accession 0001628280-21-009686, and prior-year filings.

How this page was built: the Aurinia Pharmaceuticals Inc. filed document, accession 0001628280-21-009686. Every figure is read from that document and cited to the page and table it appears in. Filed May 10, 2021.

$681K
$581K
$704K
FY18
FY19
FY20
SalaryNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
Option8,333—$5.31
Option2,917—$6.06
Option48,403—$18.38

Per the Outstanding Equity Awards at Fiscal Year-End table in Aurinia Pharmaceuticals Inc.'s FY2020 proxy; value at the fiscal year-end close, as the company printed it.

Aurinia Pharmaceuticals’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Peter GreenleafChief Executive Officer$10,679,282
Max ColaoFormer Chief Commercial Officer (8)$4,845,900
Joe MillerChief Financial Officer (7)$3,715,212
Stephen RobertsonEVP, General Counsel, Corporate Secretary and Chief Compliance Officer (9)$3,566,863
Max DonleyEVP, Operations and Strategy$3,338,217
Neil SolomonsFormer Chief Medical Officer (10)$2,977,334
Dennis Bourgeault · this pageFormer Chief Financial Officer (8)$703,715

The full Aurinia Pharmaceuticals compensation record

free company brief

This page is one person within Aurinia Pharmaceuticals's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Aurinia Pharmaceuticals proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Aurinia Pharmaceuticals's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Dennis Bourgeault's compensation dossier · One-time report. No refunds.